EMA Recommends Extension of Indications for Ribociclib to Include Use in Patients with Early Breast Cancer By Ogkologos - November 5, 2024 623 0 Facebook Twitter Google+ Pinterest WhatsApp New indication concerns the treatment of patients with early breast cancer at high risk of recurrence Source RELATED ARTICLESMORE FROM AUTHOR Noninferiority of OS with 3 Months Compared to 6 Months of Adjuvant Chemotherapy for Patients with High-Risk Stage III Colorectal Cancer Patient Guide on Bone Health in Cancer Now Available Also in French Lung Cancer Death Rates Among Women in Europe Are Finally Levelling Off MOST POPULAR Multiple mRNA Vaccines Show Promise for Treating HPV-Related Cancers April 26, 2023 Recognising the essential role of clinical research nurses October 13, 2021 Merging the Histologic and Molecular Data Into an Integrated Score Significantly... October 11, 2021 Researchers Find a Way to Prevent Cancer Cells from Taking in... July 14, 2020 Load more HOT NEWS NCI Launches New Resource for Specimens and Data from Cancer Clinical... The award-winning team transforming breast cancer treatment Seven Extra Years Our 10 top tips to help you talk about cancer
